Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Analyzers and Laboratory Information Systems Linked Through Single Workstation

By LabMedica International staff writers
Posted on 14 Oct 2010
A data management system links analyzers and laboratory information systems (LIS) through a single workstation, providing technicians with a comprehensive real-time view of the clinical laboratory testing lifecycle.

The Remisol Advance system was designed to improve laboratory turnaround times and productivity and reduce medical errors. More...
It manages the laboratory process from the initial test request, through verification and release of results, to the LIS.

The improved user interface features workflow enhancements and better usability. Utilizing the new Wide Area Networking (WAN) and Local Area Networking (LAN) configurations, it simplifies and streamlines workflow, enabling technicians to program and review test requests for all interfaced instruments.

Released by Beckman Coulter (Brea, CA, USA), the Remisol Advance v1.4 improves on existing features of the single-screen view--now providing automated STAT notifications and alerts regarding critical patient results. This minimizes processing delays and speeds up delivery of critical sample results to clinicians.

Autoverification allows tests with normal results to be released to the LIS so laboratory staff can focus on priority patient samples. In the case of critical or life-threatening results, technicians are immediately notified and provided with instructions on the next steps required to eliminate delays and reduce turnaround times.

The new system is capable of managing Beckman Coulter instruments, including automation, chemistry, special chemistry; i class integrated systems, immunoassay, hematology, and hemostasis platforms.

A Comprehensive Service package is available that starts with implementation and offers coverage throughout the lifetime of Remisol Advance.

Related Links:

Beckman Coulter





New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.